Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7043 publications
Erratum to "The fourth-generation EGFR tyrosine kinase inhibitor BLU-945 resensitizes ABCG2-overexpressing multidrug-resistant non-small cell lung cancer cells to cytotoxic anticancer drugs" [European Journal of Pharmaceutical Sciences (2025) 107337].
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: December 05, 2025
Steric disruption of EGFR oligomerization overcomes therapy resistance in non-small cell lung cancer.
Journal: Science advances
Published: December 05, 2025
Correction: Tenovin 3 induces apoptosis and ferroptosis in EGFR 19del non small cell lung cancer cells.
Journal: Scientific reports
Published: December 03, 2025
Second-line therapy following osimertinib in metastatic EGFR -mutated non-small cell lung cancer at an academic medical center.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Correction: Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR.
Journal: Cell death & disease
Published: November 20, 2025
CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancer.
Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025
Commentary: Prognostic Implications of EGFR Exon 20 Insertions in Resected Non-Small Cell Lung Cancer.
Journal: Journal of chest surgery
Published: October 17, 2025
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC - mechanisms and evolving treatment approaches.
Journal: Nature reviews. Clinical oncology
Published: October 15, 2025
Precision navigation through the labyrinth: overcoming EGFR resistance in non-Small cell lung cancer.
Journal: Annals of medicine
Published: October 15, 2025
Baicalin inhibits A549 cells proliferation and EMT through targeting the EGFR pathway.
Journal: International immunopharmacology
Published: October 09, 2025
Sunvozertinib in EGFR exon 20 insertion-mutated non-small cell lung cancer: expanding targeted therapy beyond standard EGFR inhibitors: a correspondence.
Journal: Annals of medicine and surgery (2012)
Published: October 06, 2025
Biological Differences between EGFR ex19del and ex21L858R-Preclinical Models Using an Engineered Pair of Isogenic NSCLC Cell Lines with CRISPR Engineering
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: October 06, 2025
Last Updated: 01/07/2026